What is Flotufolastat F-18: Uses, Dosage, Side Effects and More

Flotufolastat F-18 is a specialized radioactive imaging agent used to help doctors see prostate cancer cells more clearly during PET scans. This medication works like a GPS system for cancer detection, helping your medical team locate and evaluate prostate cancer that may have spread to other parts of your body.

You might feel overwhelmed hearing about a radioactive medication, but this diagnostic tool has helped thousands of patients get more accurate diagnoses. The radioactive component is carefully controlled and designed to leave your body safely within hours.

What is Flotufolastat F-18?

Flotufolastat F-18 is a radioactive diagnostic agent that targets a specific protein called PSMA (prostate-specific membrane antigen) found on prostate cancer cells. Think of it as a molecular detective that seeks out and highlights cancer cells during imaging.

This medication belongs to a class of drugs called radiopharmaceuticals. The "F-18" part refers to fluorine-18, a radioactive isotope that emits signals your PET scanner can detect. The radioactivity is short-lived and carefully measured to provide clear images while minimizing your exposure.

Your doctor will use this imaging agent when they need detailed information about where prostate cancer might be located in your body. It's particularly helpful for detecting cancer that standard imaging methods might miss.

What is Flotufolastat F-18 Used For?

This medication is primarily used to detect prostate cancer in men who have elevated PSA levels or suspected cancer recurrence. Your doctor might recommend this scan if your PSA levels are rising after previous treatment or if they need to determine how far cancer has spread.

The scan is especially valuable for finding cancer that has returned after surgery or radiation therapy. Sometimes prostate cancer can hide in lymph nodes, bones, or other organs where conventional scans struggle to detect it clearly.

Your medical team might also use this imaging when planning treatment strategies. Knowing exactly where cancer cells are located helps them choose the most effective treatment approach for your specific situation.

How Does Flotufolastat F-18 Work?

This medication works by targeting PSMA proteins that are highly concentrated on prostate cancer cells. When injected into your bloodstream, the flotufolastat molecules travel throughout your body and bind specifically to these cancer cells.

The attached fluorine-18 acts like a beacon, emitting positrons that the PET scanner can detect. This creates bright spots on the scan images wherever cancer cells are present, giving your doctor a detailed map of cancer locations.

The process is remarkably precise because healthy prostate tissue and most other organs have much lower levels of PSMA. This selectivity means the scan can distinguish between cancer cells and normal tissue with high accuracy.

How Should I Take Flotufolastat F-18?

You won't take this medication yourself - it's always administered by trained nuclear medicine professionals in a hospital or specialized imaging center. The medication is given through an intravenous (IV) line in your arm, similar to getting blood drawn.

Before your appointment, you'll need to stay well-hydrated by drinking plenty of water. Your medical team will provide specific instructions about eating and drinking before the procedure. Generally, you can eat normally unless told otherwise.

The injection itself takes just a few minutes. After receiving the medication, you'll wait about 60-90 minutes before the actual PET scan begins. This waiting period allows the medication to circulate and bind to any cancer cells present.

During the waiting period, you'll be encouraged to drink water and urinate frequently. This helps clear the medication from your bladder and reduces background radiation in the pelvic area during imaging.

How Long Should I Take Flotufolastat F-18 For?

This isn't a medication you take repeatedly - it's a one-time injection for each imaging study. The entire process, from injection to scan completion, typically takes about 3-4 hours.

The radioactive component has a short half-life, meaning it becomes less active over time. Most of the radioactivity will be gone from your body within 24 hours through natural decay and elimination.

If your doctor needs follow-up scans to monitor treatment progress, they'll schedule separate appointments. The timing between scans depends on your specific treatment plan and medical needs.

What Are the Side Effects of Flotufolastat F-18?

Most people tolerate this medication very well with minimal side effects. The most common reactions are usually mild and temporary, occurring in less than 2% of patients.

Here are the side effects you might experience, though most people have none at all:

• Mild nausea or stomach discomfort
• Temporary metallic taste in your mouth
• Slight fatigue or drowsiness
• Minor injection site reactions like redness or swelling
• Headache
• Dizziness

These reactions typically resolve within a few hours without treatment. The radioactive exposure is comparable to other medical imaging procedures and is considered safe for diagnostic purposes.

Serious allergic reactions are extremely rare but possible. Signs would include difficulty breathing, severe rash, or swelling of your face or throat. The medical team monitoring you is trained to handle any complications immediately.

Who Should Not Take Flotufolastat F-18?

This medication is specifically designed for men with prostate cancer concerns, so it's not used in women or children. However, even among men, there are some situations where your doctor might choose a different imaging approach.

Your medical team will carefully review your health history before proceeding. They'll want to know about any previous allergic reactions to contrast agents or medications, though allergies to this specific drug are extremely rare.

If you have severe kidney problems, your doctor might need to take extra precautions or consider alternative imaging methods. The medication is processed through your kidneys, so proper kidney function helps ensure safe elimination.

Men who have had recent procedures involving contrast dyes might need to wait before receiving flotufolastat F-18. Your doctor will determine the appropriate timing based on your specific situation.

Flotufolastat F-18 Brand Names

The FDA-approved brand name for this medication is Posluma. You might hear your medical team refer to it by either name - they're the same medication.

Some medical centers might also refer to it as a "PSMA PET scan" or "18F-DCFPyL scan" in their scheduling systems. These terms all describe the same imaging procedure using flotufolastat F-18.

Flotufolastat F-18 Alternatives

Several other imaging options exist for prostate cancer detection, though each has different strengths and limitations. Your doctor will choose the best option based on your specific medical situation.

Gallium-68 PSMA PET scans use a different radioactive isotope but target the same PSMA proteins. This alternative might be available at some medical centers and provides similar diagnostic information.

Traditional imaging methods like CT scans, MRI, and bone scans are still valuable tools. However, these conventional approaches may miss smaller areas of cancer that PSMA-targeted scans can detect.

Choline PET scans represent an older generation of prostate cancer imaging. While still useful in certain situations, PSMA-targeted scans like flotufolastat F-18 generally provide more accurate results.

Is Flotufolastat F-18 Better Than Gallium-68 PSMA?

Both medications target the same PSMA proteins and provide excellent cancer detection capabilities. The main differences lie in their production methods and availability rather than their diagnostic accuracy.

Flotufolastat F-18 has a longer half-life, which means it can be produced at specialized facilities and shipped to imaging centers. This makes it more widely available than gallium-68 PSMA, which must be produced on-site using expensive equipment.

From a patient perspective, both scans provide similar image quality and diagnostic information. Your doctor will choose based on what's available at your imaging facility and your specific medical needs.

The injection process, waiting times, and scan procedures are nearly identical regardless of which PSMA agent is used. Both are considered safe and effective for prostate cancer imaging.